17 alpha-hydroxyprogesterone caproate and Leukomalacia, Periventricular

17 alpha-hydroxyprogesterone caproate has been researched along with Leukomalacia, Periventricular in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dotters-Katz, SK; Goodnight, WH; Manuck, TA; Ning, A; Vladutiu, CJ	1
Abril, D; Clewell, W; Combs, CA; Das, A; Garite, TJ; Heyborne, K; How, H; Huang, W; Lewis, D; Lu, G; Maurel, K; Miller, H; Nageotte, M; Porreco, R; Sheikh, A; Tran, L	1

Trials

1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Leukomalacia, Periventricular

Article	Year
17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial. American journal of obstetrics and gynecology, 2015, Volume: 213, Issue:3 Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Cerebral Hemorrhage; Double-Blind Method; Early Termination of Clinical Trials; Enterocolitis, Necrotizing; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Hydroxyprogesterones; Infant, Newborn; Infant, Premature; Injections, Intramuscular; Leukomalacia, Periventricular; Perinatal Mortality; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Progestins; Proportional Hazards Models; Respiratory Distress Syndrome, Newborn; Sepsis; Time Factors; Treatment Outcome; Watchful Waiting; Young Adult	2015

Article

Year

17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial.

American journal of obstetrics and gynecology, 2015, Volume: 213, Issue:3

Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Cerebral Hemorrhage; Double-Blind Method; Early Termination of Clinical Trials; Enterocolitis, Necrotizing; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Hydroxyprogesterones; Infant, Newborn; Infant, Premature; Injections, Intramuscular; Leukomalacia, Periventricular; Perinatal Mortality; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Progestins; Proportional Hazards Models; Respiratory Distress Syndrome, Newborn; Sepsis; Time Factors; Treatment Outcome; Watchful Waiting; Young Adult

2015

Other Studies

1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Leukomalacia, Periventricular

Article	Year
Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth. American journal of obstetrics and gynecology, 2017, Volume: 217, Issue:3 Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Cohort Studies; Enterocolitis, Necrotizing; Female; Gestational Age; Humans; Hydroxyprogesterones; Infant; Infant Mortality; Leukomalacia, Periventricular; Male; North Carolina; Pregnancy; Premature Birth; Progestins; Recurrence; Retrospective Studies	2017

Article

Year

Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth.

American journal of obstetrics and gynecology, 2017, Volume: 217, Issue:3

Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Cohort Studies; Enterocolitis, Necrotizing; Female; Gestational Age; Humans; Hydroxyprogesterones; Infant; Infant Mortality; Leukomalacia, Periventricular; Male; North Carolina; Pregnancy; Premature Birth; Progestins; Recurrence; Retrospective Studies

2017